NCT00187798View on ClinicalTrials.gov

Impact of Genetics on Metformin Pharmacokinetics

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
Other Conditions That May Be A Focus of Clinical Attention
Interventions
DRUG

Metformin HCl

Subjects will be given a single oral dose in tablet form containing 850 mg of metformin

Trial Locations (1)

94143

University of California San Francsico, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00187798 - Impact of Genetics on Metformin Pharmacokinetics | Biotech Hunter | Biotech Hunter